PJT · Insider Trading
PJT Partners Inc.
Every open-market purchase and sale reported by PJT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Kievdi Don Cornwell | Director | A | +32 deriv. | — |
| 2026-09-18 | Thomas M Ryan | Director | A | +19 deriv. | — |
| 2026-09-18 | James Costos | Director | A | +15 deriv. | — |
| 2026-09-18 | Peter L S Currie | Director | A | +5 deriv. | — |
| 2026-09-18 | Grace Reksten Skaugen | Director | A | +9 deriv. | — |
| 2026-09-18 | Emily K Rafferty | Director | A | +9 deriv. | — |
| 2026-09-18 | David Adam Travin | General Counsel | A | +12 deriv. | — |
| 2026-09-18 | Kenneth C Whitney | Director | A | +9 deriv. | — |
| 2026-09-18 | Helen T Meates | Chief Financial Officer | A | +21 deriv. | — |
| 2026-09-18 | Ji-Yeun Lee | Managing Partner | A | +30 deriv. | — |
| 2026-08-21 | James Costos | Director | Sell | −1,723 | −$301.52K |
| 2026-08-21 | Kievdi Don Cornwell | Director | Sell | −7,845 | −$1.36M |
| 2026-08-10 | Emily K Rafferty | Director | Sell | −1,100 | −$184.09K |
| 2026-08-03 | Paul J Taubman | Chairman and CEO | M | −36,000 deriv. | — |
| 2026-07-31 | Grace Reksten Skaugen | Director | Sell | −1,283 | −$215.12K |
| 2026-06-18 | Ji-Yeun Lee | Managing Partner | A | +30 deriv. | — |
| 2026-06-18 | Emily K Rafferty | Director | A | +8 deriv. | — |
| 2026-06-18 | Kievdi Don Cornwell | Director | A | +30 deriv. | — |
| 2026-06-18 | Kenneth C Whitney | Director | A | +8 deriv. | — |
| 2026-06-18 | Helen T Meates | Chief Financial Officer | A | +21 deriv. | — |
| 2026-06-18 | James Costos | Director | A | +14 deriv. | — |
| 2026-06-18 | Thomas M Ryan | Director | A | +17 deriv. | — |
| 2026-06-18 | Grace Reksten Skaugen | Director | A | +8 deriv. | — |
| 2026-06-18 | David Adam Travin | General Counsel | A | +11 deriv. | — |
| 2026-06-18 | Peter L S Currie | Director | A | +3 deriv. | — |
| 2026-06-03 | Peter L S Currie | Director | A | +1,600 deriv. | — |
| 2026-06-03 | Kenneth C Whitney | Director | M | +1,283 | — |
| 2026-06-03 | Kievdi Don Cornwell | Director | A | +1,600 deriv. | — |
| 2026-06-03 | James Costos | Director | M | +1,929 | — |
| 2026-06-03 | Grace Reksten Skaugen | Director | M | +1,283 | — |
| 2026-06-03 | Thomas M Ryan | Director | M | +2,570 | — |
| 2026-06-03 | Emily K Rafferty | Director | M | +1,541 | — |
| 2026-05-08 | David Adam Travin | General Counsel | Sell | −3,000 | −$457.28K |
| 2026-05-01 | Helen T Meates | Chief Financial Officer | Sell | −8,000 | −$1.23M |
| 2026-05-01 | Paul J Taubman | Chairman and CEO | M | −36,000 deriv. | — |
| 2026-03-20 | Kievdi Don Cornwell | Director | A | +35 deriv. | — |
| 2026-03-20 | Kenneth C Whitney | Director | A | +12 deriv. | — |
| 2026-03-20 | Ji-Yeun Lee | Managing Partner | A | +35 deriv. | — |
| 2026-03-20 | Grace Reksten Skaugen | Director | A | +12 deriv. | — |
| 2026-03-20 | Thomas M Ryan | Director | A | +24 deriv. | — |
| 2026-03-20 | David Adam Travin | General Counsel | A | +14 deriv. | — |
| 2026-03-20 | James Costos | Director | A | +19 deriv. | — |
| 2026-03-20 | Helen T Meates | Chief Financial Officer | A | +25 deriv. | — |
| 2026-03-20 | Emily K Rafferty | Director | A | +12 deriv. | — |
| 2026-03-20 | Peter L S Currie | Director | A | +3 deriv. | — |
| 2026-03-03 | David Adam Travin | General Counsel | M | +5,052 | — |
| 2026-03-03 | Helen T Meates | Chief Financial Officer | M | +9,627 | — |
| 2026-03-03 | Kievdi Don Cornwell | Director | M | +18,865 | — |
| 2026-03-03 | Ji-Yeun Lee | Managing Partner | M | +12,944 | — |
| 2026-02-11 | David Adam Travin | General Counsel | A | +6,823 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Paul J Taubman | Chairman and CEO | 400,000 | $54.88M |
| Ji-Yeun Lee | Managing Partner | 88,402 | $12.13M |
| Helen T Meates | Chief Financial Officer | 58,752 | $8.06M |
| Thomas M Ryan | Director | 41,964 | $5.76M |
| Kievdi Don Cornwell | Director | 18,865 | $2.59M |
| Kenneth C Whitney | Director | 12,106 | $1.66M |
| James Costos | Director | 11,289 | $1.55M |
| Emily K Rafferty | Director | 9,568 | $1.31M |
| David Adam Travin | General Counsel | 2,052 | $281.55K |
| Grace Reksten Skaugen | Director | 500 | $68.61K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PJT quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.